Live Analyst Rating Changes 23058 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/David Kwan
TD

David Kwan

TD Cowen
Wall Street Analyst
★★★★☆
#922
on 13Foresight · ranked by our own returns
65%
Success Rate
+6.8%
Average Return
13 of 20 calls profitable · -2.3% vs benchmark
S&P 500 (SPY)
🔒 5-year track record is Pro. Showing 1-year — upgrade.
📈 Across the calls we could measure, roughly 65% of David Kwan's ratings turned a profit when each position was held for 1 year — averaging +6.8% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

33 Buy 12 Hold 4 Sell
David's Stock Coverage 16 ratings · 2026-08-12
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
TSE:AIDX
HEALWELL AI
 Aug 10, 2026 BUY Strong Buy
+194.9% avg upside
10 analysts
$1.75
139.79% Upside
 · ·
TSE:TOI
Topicus.com
 Aug 06, 2026 BUY Strong Buy
+39.4% avg upside
3 analysts
$145.00
41.05% Upside
 · ·
TSE:OTEX
Open Text
 Aug 06, 2026 HOLD Buy
+42.7% avg upside
18 analysts
$37.82
13.40% Upside
 -3.5% ·
TSE:LMN
Lumine Group Inc
 Aug 05, 2026 BUY Strong Buy
+47.3% avg upside
2 analysts
$42.00
60.64% Upside
 · ·
TSE:CVO
Coveo Solutions
 Jul 31, 2026 BUY Strong Buy
+122.4% avg upside
11 analysts
$7.00
55.95% Upside
 -0.9% ·
TSE:GIB.A
CGI
 Jul 29, 2026 HOLD Buy
+17.0% avg upside
20 analysts
$118.00
13.11% Upside
 -0.6% ·
TSE:ENGH
Enghouse Systems
 Jun 11, 2026 HOLD Hold
+89.2% avg upside
6 analysts
$16.00
8.23% Downside
 +9.9% ·
TSE:KSI
kneat.com
 Jun 08, 2026 SELL Buy
-9.4% avg upside
8 analysts
$6.50
0.06% Downside
 -0.8% ·
TSE:STC
Sangoma Technologies
 May 14, 2026 BUY Strong Buy
+61.1% avg upside
5 analysts
$8.00
38.82% Upside
 +11.0% ·
TSE:CSU
Constellation Software
 May 13, 2026 BUY Strong Buy
+10.6% avg upside
12 analysts
$4200.00
30.39% Upside
 +30.6% ·
TSE:VHI
Vitalhub
 Nov 07, 2025 BUY Strong Buy
+72.1% avg upside
8 analysts
$15.00
92.80% Upside
 -22.8% ·
TSE:WELL
WELL Health Technologies Corp
 Apr 16, 2025 BUY Strong Buy
+65.1% avg upside
11 analysts
$7.50
78.66% Upside
 +4.3% ·
TSE:VCM
Vecima Networks
 Nov 13, 2020 BUY Strong Buy
+43.8% avg upside
4 analysts
$18.25
43.67% Upside
 +18.5% ·
TSE:BYL
Baylin Tech
 Nov 13, 2020 HOLD Buy
+466.7% avg upside
3 analysts
$1.30
400.07% Upside
 -1.1% ·
TSE:MTLO
Martello Technologies Group Inc
 May 26, 2020 BUY Strong Buy
+8150.0% avg upside
4 analysts
$0.45
8899.93% Upside
 · ·
TSE:HIVE
HIVE Digital Technologies
 Oct 01, 2019 HOLD Strong Buy
+144.0% avg upside
13 analysts
 — +63.6% ·
🔒 11 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
David Kwan — Frequently Asked Questions
How accurate are David Kwan's stock ratings?
Based on the calls 13Foresight could measure, about 65% of David's ratings were profitable over a one-year hold, with an average return of +6.8% per rating, or -2.3% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is David ranked on 13Foresight?
David Kwan is currently ranked #922 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does David cover?
David most recently has ratings on TSE:AIDX, TSE:TOI, TSE:OTEX, TSE:LMN, TSE:CVO, TSE:GIB.A, TSE:ENGH, TSE:KSI, TSE:STC, TSE:CSU, TSE:VHI, TSE:WELL and 4 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.